Skip to content

Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U

Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U 1

Population-based data evaluating cause-specific mortality in patients with psoriasis are limited. Smaller, non population-based studies of patients with severe psoriasis (i.e., those hospitalized for their disease or derived from clinical trial populations from tertiary care medical centers) also found higher mortality rates among psoriasis patients than among the general population, particularly for cardiovascular disease,21 22 cancer,21, 23 and liver disease. We performed a cohort study to determine the risk of the most common forms of death in patients with severe psoriasis, using the General Practice Research Database (GPRD) from the United Kingdom. You are here: NCBI Literature PubMed Central (PMC). We were able to sign you in, but your subscription(s) could not be found. Population-based data evaluating cause-specific mortality in patients with psoriasis are limited. Register and you can start organising your references online. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.

Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U 2More info Close By continuing to browse the site you are agreeing to our use of cookies. Design Population based cohort study and nested cross sectional study. Conclusions Moderate to severe psoriasis is associated with an increased risk of chronic kidney disease independent of traditional risk factors. 8 We previously conducted a population based cohort study examining cause specific mortality in people with psoriasis and found a fourfold increase in death from nephritic or non-hypertensive kidney disease among those with severe psoriasis. Do patients with psoriasis–especially if it is severe — have an increased risk of chronic kidney disease? You will be notified when new articles are posted to this topic. Population based cohort study and nested cross sectional study. This population-based cohort study compares the overall risk of cancer, including nonmelanoma skin cancer, lymphoma, and lung cancer in patients with and without psoriasis.

We conducted a cohort study using the General Practice Research Database to determine if severe psoriasis patients have an increased risk of cardiovascular (CV) mortality. Severe psoriasis was an independent risk factor for CV mortality (HR 1. The risk of mortality in patients with psoriasis: results from a population-based study. Severe psoriasis was associated with a significantly increased risk of cardiovascular mortality (RR, 1. Because 2 studies used standardized mortality ratios based on a population sample, we assumed that the control groups in each case consisted of an equal number of patients matched by age and sex with the same duration of follow-up as the psoriasis group. Cardiovascular mortality was studied among 4 cohorts, including patients from the United States, United Kingdom, Sweden, and Denmark (Figure 2). Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U. Troxel, A.B., Gelfand, J.M. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol. 42Kimball, A.B., Szapary, P., Mrowietz, U. et al, Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis.

Risk Of Moderate To Advanced Kidney Disease In Patients With Psoriasis: Population Based Cohort Study

Smoking may also be a risk factor in the development of psoriasis 3Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol. 2010 Sep; 163(3):586-92. How has UCSF Profiles helped you? 2Dubertret, L, Mrowietz, U, Ranki, A.., and the EUROPSO Patient Survey Group., and the EUROPSO Patient Survey Group. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the UK. Association of psoriasis with stroke and myocardial infarction: meta-analysis of cohort studies. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: results from a population-based study. This population-based cohort study identified 40,637 patients with psoriasis and 162,548 subjects without psoriasis matched by age, sex, history of coronary artery disease, hypertension, and diabetes in the Taiwan National Health Insurance Research Database during 2004 through 2006. 2: Lindstrm U, Bremander A, Haglund E, Bergman S, Petersson IF, Jacobsson LT. Costs for Psoriasis and Psoriatic Arthritis in a Population-based Cohort in Southern Sweden: Is It All Psoriasis-attributable Morbidity?. A nationwide health economic study based on five defined cohorts. J Dermatolog Treat. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. I. Causes and risk of death. To continue reading this article, you must log in with your personal, hospital, or group practice subscription. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U. The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan.

Patients With Severe Psoriasis Are At Increased Risk Of Cardiovascular Mortality: Cohort Study Using The General Practice Research Database

Skin and serum from patients with psoriasis were evaluated to understand if there was evidence of dysregulation in a targeted group of inflammatory and lipid genes related to ASCVD. Recommendation based on consensus, opinion, or case studies. Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom. Cause-specific mortality in patients with severe psoriasis: A population-based cohort study in the United Kingdom. Tachyphylaxis to topical corticosteroids: the more you use them, the less they work? Secukinumab (AIN457) patients’ skin cleared faster and for longer than Enbrel (etanercept) patients, beginning as early as Week 2 1. Research shows that IL-17A, in particular, plays a key role in driving the body’s autoimmune response in disorders such as moderate-to-severe plaque psoriasis and is a preferred target for investigational therapies 2 – 6. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U. You are here.